New drug tested to ease debilitating knee arthritis pain
NCT ID NCT05618782
Summary
This study tested whether an investigational drug called LEVI-04 could safely reduce pain and improve physical function in people with knee osteoarthritis. Over 500 participants with moderate to severe knee pain received either the drug or a placebo injection. The main goal was to see if LEVI-04 led to a greater reduction in pain scores compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CCR Brno, s.r.o
Brno, Czechia
-
CCR Czech a.s
Pardubice, Czechia
-
CCR Prague, s.r.o
Prague, Czechia
-
Hong Kong Center for Clinical Research
Hong Kong, Hong Kong
-
Medyczne Centrum Hetmańska
Poznan, Poland
-
NZOZ Bif-Med. s.c.
Bytom, Poland
-
PMSI Cardiology Institute/RTL SM SRL Consultative ward
Chisinau, Moldova
-
PMSI Clinical Republican Hospital "Timofei Mosneaga"
Chisinau, Moldova
-
Sanos Clinic Herlev
Herlev, Denmark
-
Sanos Clinic Nordjylland
Gandrup, Denmark
-
Sanos Clinic Syddanmark
Vejle, Denmark
-
Somed CR
Lodz, Poland
-
Somed CR
Warsaw, Poland
Conditions
Explore the condition pages connected to this study.